within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10B_BloodGlucoseLoweringDrugsExclInsulins.A10BH02_Vildagliptin;

model Vildagliptin
  extends Pharmacolibrary.Drugs.ATC.A.A10BH02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A10BH02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Vildagliptin is an oral antidiabetic drug of the dipeptidyl peptidase-4 (DPP-4) inhibitor class, used in the management of type 2 diabetes mellitus to improve glycaemic control. It is approved for use in several countries worldwide.</p><h4>Pharmacokinetics</h4><p>Healthy adult volunteers, both male and female, after a single oral dose administration.</p><h4>References</h4><ol><li><p>Tian, M, et al., &amp; Yang, S (2025). Pharmacokinetics and Bioequivalence of 2 Oral Formulations of Vildagliptin in Healthy Chinese Subjects. <i>Clinical pharmacology in drug development</i> 14(2) 154–160. DOI:<a href=\"https://doi.org/10.1002/cpdd.1482\">10.1002/cpdd.1482</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39444294/\">https://pubmed.ncbi.nlm.nih.gov/39444294</a></p></li><li><p>Wang, X, et al., &amp; Wang, W (2010). Pharmacokinetics of lipoyl vildagliptin, a novel dipeptidyl peptidase IV inhibitor after oral administration in rats. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 40(10) 707–712. DOI:<a href=\"https://doi.org/10.3109/00498254.2010.511683\">10.3109/00498254.2010.511683</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20735236/\">https://pubmed.ncbi.nlm.nih.gov/20735236</a></p></li><li><p>He, YL (2012). Clinical pharmacokinetics and pharmacodynamics of vildagliptin. <i>Clinical pharmacokinetics</i> 51(3) 147–162. DOI:<a href=\"https://doi.org/10.2165/11598080-000000000-00000\">10.2165/11598080-000000000-00000</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22339447/\">https://pubmed.ncbi.nlm.nih.gov/22339447</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Vildagliptin;
